PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
•2.1 Preface
•2.2 Preface
•2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
•Market ecosystem
•Market characteristics
•Market segmentation analysis

PART 04: MARKET SIZING
•Market definition
•Market sizing 2018
•Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS
•Bargaining power of buyers
•Bargaining power of suppliers
•Threat of new entrants
•Threat of substitutes
•Threat of rivalry
•Market condition

PART 06: MARKET SEGMENTATION BY END-USER
•Market segmentation by end-user
•Comparison by end-user
•Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023
•Clinical and reference laboratories - Market size and forecast 2018-2023
•Academic institutes and research organizations - Market size and forecast 2018-2023
•Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
•Geographic segmentation
•Geographic comparison
•North America - Market size and forecast 2018-2023
•Europe - Market size and forecast 2018-2023
•Asia - Market size and forecast 2018-2023
•ROW - Market size and forecast 2018-2023
•Key leading countries
•Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
•Market drivers
•Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
•Overview
•Landscape disruption

PART 13: VENDOR ANALYSIS
•Vendors covered
•Vendor classification
•Market positioning of vendors
•Agilent Technologies
•Danaher
•PerkinElmer
•QIAGEN
•Thermo Fisher Scientific

PART 14: APPENDIX
•Research methodology
•List of abbreviations

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: End-user - Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
Exhibit 21: Clinical and reference laboratories - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Clinical and reference laboratories - Year-over-year growth 2019-2023 (%)
Exhibit 23: Academic institutes and research organizations - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Academic institutes and research organizations - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Agilent Technologies - Vendor overview
Exhibit 46: Agilent Technologies - Business segments
Exhibit 47: Agilent Technologies - Organizational developments
Exhibit 48: Agilent Technologies - Geographic focus
Exhibit 49: Agilent Technologies - Segment focus
Exhibit 50: Agilent Technologies - Key offerings
Exhibit 51: Danaher - Vendor overview
Exhibit 52: Danaher - Business segments
Exhibit 53: Danaher - Organizational developments
Exhibit 54: Danaher - Geographic focus
Exhibit 55: Danaher - Segment focus
Exhibit 56: Danaher - Key offerings
Exhibit 57: PerkinElmer - Vendor overview
Exhibit 58: PerkinElmer - Business segments
Exhibit 59: PerkinElmer - Organizational developments
Exhibit 60: PerkinElmer - Geographic focus
Exhibit 61: PerkinElmer - Segment focus
Exhibit 62: PerkinElmer - Key offerings
Exhibit 63: QIAGEN - Vendor overview
Exhibit 64: QIAGEN - Business segments
Exhibit 65: QIAGEN - Organizational developments
Exhibit 66: QIAGEN - Geographic focus
Exhibit 67: QIAGEN - Segment focus
Exhibit 68: QIAGEN - Key offerings
Exhibit 69: Thermo Fisher Scientific - Vendor overview
Exhibit 70: Thermo Fisher Scientific - Business segments
Exhibit 71: Thermo Fisher Scientific - Organizational developments
Exhibit 72: Thermo Fisher Scientific - Geographic focus
Exhibit 73: Thermo Fisher Scientific - Segment focus
Exhibit 74: Thermo Fisher Scientific - Key offerings

Companies Mentioned
. Agilent Technologies
. Danaher
. PerkinElmer
. QIAGEN
. Thermo Fisher Scientific